在青少年中探索自杀恐惧和药物治疗之间的联系:来自临床队列的证据
Francesca Marazzi1,2, Marika Orlandi1,2, Arianna Vecchio2
1Department of Brain and Behavioral Sciences, University of Pavia, 27100 Pavia, Italy.
Journal of clinical medicine
|September 27, 2025
概括
自杀恐惧 (SC) 的青少年接受了更多的抗精神病药物和补充剂,表明SC影响青少年精神病药物选择超出了诊断范围. 这凸显了需要将SC视为一个独特的目标.
科学领域:
- 儿童和青少年精神病学
- 公共卫生 公共卫生
- 药理学 药理学是指药理学的学科.
背景情况:
- 青少年自杀风险是一个重要的公共卫生问题.
- 青少年的药物治疗通常针对疾病,而不是直接针对自杀风险.
- 现有的青少年自杀恐惧 (SC) 治疗方法很复杂.
研究的目的:
- 调查住院青少年中自杀恐惧 (SC) 和精神药物处方之间的联系.
- 为了确定自杀风险水平是否预测出院时的药物治疗.
- 分析与SC有关的药理治疗模式.
主要方法:
- 对224名住院青少年进行横截面研究.
- 使用哥伦比亚自杀严重性评级表 (C-SSRS) 评估SC.
- 在入院 (T0) 和出院 (T1) 时比较精神药物处方,控制共变量.
主要成果:
- 患有SC的青少年有更严重的临床表现.
- SC组在出院时接受了更多的抗精神病药物和补充剂.
- SC预测了抗精神病药物和补充剂的处方,独立于诊断.
结论:
- 自杀的担忧 (SC) 影响了青少年超越诊断的精神药物处方.
- 治疗决定可能反映了SC的风险控制策略.
- 在青少年精神病学中,SC值得考虑作为一个独立的治疗目标.
相关概念视频
Drug Therapy
245
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
245
Psychosis: Goals of Pharmacotherapy
474
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
474
Antidepressant Drugs: MAOIs and Other Agents
828
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
828
Antidepressant Drugs: Overview
1.4K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.4K
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Therapeutic Drug Monitoring: Affecting Factors
201
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
201


